Anti‐VEGF for neovascular ARMD: visual improvement as the goal of therapy?
AUTOR(ES)
Bopp, Silvia
FONTE
BMJ Group
RESUMO
There has been dramatic progress in anti‐VEGF therapy, but future guidelines are needed
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2001031Documentos Relacionados
- Photodynamic therapy in the anti‐VEGF era
- Técnica de injeção intravítrea de anti-VEGF sem compasso
- Effectiveness of monthly and fortnightly anti-VEGF treatments for age-related macular degeneration
- Effect of anti‐VEGF antibody on retinal ganglion cells in rats
- Comparação do efeito da terapia anti-VEGF (bevacizumab) subconjuntival e tópica na neovascularização corneana experimental